SPDR® MSCI EAFE Quality Mix ETF
Most Recent
Of GSK’s Business Segments, This One Is the Sales Laggard
GlaxoSmithKline (GSK) reported a growth of 10.9% in its revenues to 6.5 billion pounds for 2Q16.
Most Recent
GlaxoSmithKline (GSK) reported a growth of 10.9% in its revenues to 6.5 billion pounds for 2Q16.